PortfoliosLab logoPortfoliosLab logo
HQL vs. ASG
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

HQL vs. ASG - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Tekla Life Sciences Investors (HQL) and Liberty All-Star Growth (ASG). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, HQL achieves a 7.78% return, which is significantly higher than ASG's 4.45% return. Over the past 10 years, HQL has underperformed ASG with an annualized return of 9.66%, while ASG has yielded a comparatively higher 11.85% annualized return.


HQL

1D
0.53%
1M
-3.82%
YTD
7.78%
6M
5.52%
1Y
49.53%
3Y*
21.36%
5Y*
7.13%
10Y*
9.66%

ASG

1D
-0.19%
1M
2.51%
YTD
4.45%
6M
4.45%
1Y
9.56%
3Y*
8.78%
5Y*
-1.22%
10Y*
11.85%
*Multi-year figures are annualized to reflect compound growth (CAGR)

HQL vs. ASG - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
HQL
Tekla Life Sciences Investors
7.78%45.48%11.03%4.23%-19.21%5.52%23.72%25.53%-16.18%25.41%
ASG
Liberty All-Star Growth
4.45%2.21%16.78%16.23%-40.91%22.60%37.99%60.54%-14.35%44.64%

Correlation

The correlation between HQL and ASG is 0.47, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.47

Correlation (3Y)
Calculated over the trailing 3-year period

0.49

Correlation (5Y)
Calculated over the trailing 5-year period

0.53

Correlation (10Y)
Calculated over the trailing 10-year period

0.49

Correlation (All Time)
Calculated using the full available price history since May 4, 1992

0.43

The correlation between HQL and ASG shifts across timeframes, from 0.43 (all time) to 0.53 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

HQL:

$515.42M

ASG:

$333.17M

EPS

HQL:

$6.27

ASG:

$1.04

PE Ratio

HQL:

2.70

ASG:

5.11

PS Ratio

HQL:

6.29

ASG:

4.90

PB Ratio

HQL:

0.92

ASG:

0.90

Total Revenue (TTM)

HQL:

$79.82M

ASG:

$67.50M

Gross Profit (TTM)

HQL:

$56.06M

ASG:

$57.76M

EBITDA (TTM)

HQL:

$150.93M

ASG:

$61.00M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

HQL vs. ASG — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HQL
HQL Risk / Return Rank: 9191
Overall Rank
HQL Sharpe Ratio Rank: 9292
Sharpe Ratio Rank
HQL Sortino Ratio Rank: 9090
Sortino Ratio Rank
HQL Omega Ratio Rank: 8888
Omega Ratio Rank
HQL Calmar Ratio Rank: 9292
Calmar Ratio Rank
HQL Martin Ratio Rank: 9393
Martin Ratio Rank

ASG
ASG Risk / Return Rank: 5555
Overall Rank
ASG Sharpe Ratio Rank: 5959
Sharpe Ratio Rank
ASG Sortino Ratio Rank: 5050
Sortino Ratio Rank
ASG Omega Ratio Rank: 4949
Omega Ratio Rank
ASG Calmar Ratio Rank: 5555
Calmar Ratio Rank
ASG Martin Ratio Rank: 6262
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

HQL vs. ASG - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Tekla Life Sciences Investors (HQL) and Liberty All-Star Growth (ASG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


HQLASGDifference
Sharpe ratioReturn per unit of total volatility

+1.81

Sortino ratioReturn per unit of downside risk

+2.32

Omega ratioGain probability vs. loss probability

1.37

1.09

+0.28

Calmar ratioReturn relative to maximum drawdown

4.71

0.52

+4.19

Martin ratioReturn relative to average drawdown

15.05

1.92

+13.13

HQL vs. ASG - Sharpe Ratio Comparison

The current HQL Sharpe Ratio is 2.27, which is higher than the ASG Sharpe Ratio of 0.46. The chart below compares the historical Sharpe Ratios of HQL and ASG, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

HQL vs. ASG - Drawdown Comparison

The maximum HQL drawdown since its inception was -62.65%, smaller than the maximum ASG drawdown of -66.77%. Use the drawdown chart below to compare losses from any high point for HQL and ASG.


Loading charts...

Drawdown Indicators


HQLASGDifference

Max Drawdown

Largest peak-to-trough decline

-62.65%

-66.77%

+4.12%

Max Drawdown (1Y)

Largest decline over 1 year

-10.25%

-15.77%

+5.52%

Max Drawdown (3Y)

Largest decline over 3 years

-25.10%

-25.25%

+0.15%

Max Drawdown (5Y)

Largest decline over 5 years

-38.86%

-45.91%

+7.05%

Max Drawdown (10Y)

Largest decline over 10 years

-38.86%

-45.91%

+7.05%

Current Drawdown

Current decline from peak

-5.10%

-18.82%

+13.72%

Average Drawdown

Average peak-to-trough decline

-22.25%

-17.61%

-4.64%

Ulcer Index

Depth and duration of drawdowns from previous peaks

3.22%

4.24%

-1.02%

Volatility

HQL vs. ASG - Volatility Comparison

Tekla Life Sciences Investors (HQL) has a higher volatility of 6.62% compared to Liberty All-Star Growth (ASG) at 5.91%. This indicates that HQL's price experiences larger fluctuations and is considered to be riskier than ASG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


HQLASGDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.62%

5.91%

+0.71%

Volatility (6M)

Calculated over the trailing 6-month period

14.44%

14.01%

+0.43%

Volatility (1Y)

Calculated over the trailing 1-year period

21.26%

17.80%

+3.46%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

20.63%

22.85%

-2.22%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

22.24%

25.08%

-2.84%

Dividends

HQL vs. ASG - Dividend Comparison

HQL's dividend yield for the trailing twelve months is around 12.04%, more than ASG's 8.87% yield.


PositionTTM20252024202320222021202020192018201720162015
ASG
Liberty All-Star Growth
8.87%8.68%8.32%8.14%10.14%11.33%7.68%7.08%10.48%7.58%8.61%16.81%
HQL
Tekla Life Sciences Investors
12.04%10.85%14.18%9.44%9.57%8.79%7.90%8.03%10.72%8.25%12.18%11.84%

Financials

HQL vs. ASG - Financials Comparison

This section allows you to compare key financial metrics between Tekla Life Sciences Investors and Liberty All-Star Growth. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


-10.00M0.0010.00M20.00M30.00M40.00M50.00M20222023202420252026
48.07M
7.29M
(HQL) Total Revenue
(ASG) Total Revenue
Values in USD except per share items

Frequently Asked Questions


HQL and ASG have a correlation of 0.47, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

HQL has higher volatility (6.62%) compared to ASG (5.91%). In terms of maximum drawdown, HQL dropped -62.65% vs ASG's -66.77%.

HQL currently has the higher Sharpe Ratio (2.27 vs 0.46), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for HQL and ASG

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer